The relationship between COVID‐19 viral load and disease severity: A systematic review
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Introduction: Patients with COVID‐19 may present different viral loads levels. However, the relationship between viral load and disease severity in COVID‐19 is still unknown. Therefore, this study aimed to systematically review the association between SARS‐CoV‐2 viral load and COVID‐19 severity. Methods: The relevant studies using the keywords of “COVID‐19” and “viral load” were searched in the databases of PubMed, Scopus, Google Scholar, and Web of Science. A two‐step title/abstract screening process was carried out and the eligible studies were included in the study. Results: Thirty‐four studies were included from the initial 1015 records. The vast majority of studies have utilized real‐time reverse transcription‐polymerase chain reaction of the nasopharyngeal/respiratory swabs to report viral load. Viral loads were commonly reported either as cycle threshold (Ct) or log 10 RNA copies/ml. Conclusion: The results were inconclusive about the relationship between COVID‐19 severity and viral load, as a similar number of studies either approved or opposed this hypothesis. However, the studies denote the direct relationship between older age and higher SARS‐CoV‐2 viral load, which is a known risk factor for COVID‐19 mortality. The higher viral load in older patients may serve as a mechanism for any possible relationships between COVID‐19 viral load and disease severity. There was a positive correlation between SARS‐CoV‐2 viral load and its transmissibility. Nonetheless, further studies are recommended to precisely characterize this matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810 · cited 1×
“Thus, the study of the correlation between COVID‐19 viral load and the progression of the disease and the treatment and prevention of COVID‐19 helps to science promotion significantly.(22) A Chinese study working on the association of viral load with the development of COVID‐19 found that patients with more viral load…”
BackgroundTo, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066 · cited 1×
“*** – *** 6 To et al.(52) *** ** ** 7 To et al.”
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · cited 1×
“SARS‐CoV‐2 belongs to the Nidovirales order, Coronaviridae family, Coronavirinae subfamily, it is an enveloped virus with a positive‐sense, single‐stranded RNA genome of approximately 30 kb.(13) Since its emergence, the SARS‐CoV‐2 has undergone multiple mutations resulting in weaker or even or more dangerous variants…”
BackgroundConsistent Detection of 2019 Novel Coronavirus in Saliva
To, K. K.-W., Tsang, O. T.-Y., Yip, C. C.-Y., Chan, K.-H., Wu, T.-C., Chan, J. M.-C., Leung, W.-S., Chik, T. S.-H., Choi, C. Y.-C., Kandamby, D. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa149 · Cited by 1,873 · cited 1×
“*** ** ** 7 To et al.(53) *** ** ** 7 Trunfio et al.”
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., Xie, G., Lin, S., Wang, R., Yang, X., et al. (2020) · BMJ · doi:10.1136/bmj.m1443 · Cited by 1,440
Singanayagam, A., Patel, M., Charlett, A., Lopez Bernal, J., Saliba, V., Ellis, J., Ladhani, S., Zambon, M., & Gopal, R. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.32.2001483 · Cited by 846
Kinetics of viral load and antibody response in relation to COVID-19 severity
Wang, Y., Zhang, L., Sang, L., Ye, F., Ruan, S., Zhong, B., Song, T., Alshukairi, A. N., Chen, R., Zhang, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138759 · Cited by 541 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Meng, B., Kemp, S. A., Papa, G., Datir, R., Ferreira, I. A. T. M., Marelli, S., Harvey, W. T., Lytras, S., Mohamed, A., Gallo, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109292 · Cited by 405
Ranzani, O. T., Hitchings, M. D. T., Dorion, M., D’Agostini, T. L., de Paula, R. C., de Paula, O. F. P., Villela, E. F. D. M., Torres, M. S. S., de Oliveira, S. B., Schulz, W., et al. (2021) · BMJ · doi:10.1136/bmj.n2015 · Cited by 348
Rabaan, A. A., Al-Ahmed, S. H., Muhammad, J., Khan, A., Sule, A. A., Tirupathi, R., Mutair, A. A., Alhumaid, S., Al-Omari, A., Dhawan, M., et al. (2021) · Vaccines · doi:10.3390/vaccines9050436 · Cited by 255 · cited 1×
“When an infection in the lower respiratory tract activates immune cells such as neutrophils and macrophages, it releases several chemokines and cytokines that activate the immune system like B and T cells, this irregular response eventually leads to elevated levels of cytokines, called cytokine storms or hypercytokine…”
BackgroundViral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
Rabaan, A. A., Tirupathi, R., Sule, A. A., Aldali, J., Mutair, A. A., Alhumaid, S., Muzaheed, Gupta, N., Koritala, T., Adhikari, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11061091 · Cited by 220 · cited 1×
“When SARS‐CoV‐2 enters lung cells, it attacks the lower respiratory tract and attaches strongly to its receptors in the lungs; namely, angiotensin‐converting enzyme receptors.(8,9) When an infection in the lower respiratory tract activates immune cells such as neutrophils and macrophages, it releases several chemokine…”
BackgroundPredictors of mortality in patients with COVID-19–a systematic review
Mehraeen, E., Karimi, A., Barzegary, A., Vahedi, F., Afsahi, A. M., Dadras, O., Moradmand-Badie, B., Seyed Alinaghi, S. A., & Jahanfar, S. (2020) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2020.101226 · Cited by 170 · cited 1×
“The symptoms of COVID‐19 are fever, dry cough, dyspnea, headache, fatigue, loss of taste and/or smell, and gastrointestinal symptoms.(11) In laboratory results the liver enzymes are high, lymphocytes are low (lymphocytopenia), and C‐reactive protein levels are high.”
BackgroundSelf-citationViral load of SARS-CoV-2 across patients and compared to other respiratory viruses
Jacot, D., Greub, G., Jaton, K., & Opota, O. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.08.004 · Cited by 159 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Kawasuji, H., Takegoshi, Y., Kaneda, M., Ueno, A., Miyajima, Y., Kawago, K., Fukui, Y., Yoshida, Y., Kimura, M., Yamada, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243597 · Cited by 150 · cited 3×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
InfluentialLate Complications of COVID-19; a Systematic Review of Current Evidence.
SeyedAlinaghi, S., Afsahi, A. M., MohsseniPour, M., Behnezhad, F., Salehi, M. A., Barzegary, A., Mirzapour, P., Mehraeen, E., & Dadras, O. (2021) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v9i1.1058 · Cited by 134
Self-citationSeyedAlinaghi, S., Mirzapour, P., Dadras, O., Pashaei, Z., Karimi, A., MohsseniPour, M., Soleymanzadeh, M., Barzegary, A., Afsahi, A. M., Vahedi, F., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00524-8 · Cited by 126 · cited 1×
“SARS‐CoV‐2 continuously evolves and potentially becomes more transmissible or fatal with each mutation.(2) Four variants of SARS‐CoV‐2 have been declared as the “variants of concern” by the WHO so far, which cause COVID‐19.”
BackgroundSelf-citationEffects of COVID-19 prevention procedures on other common infections: a systematic review
Dadras, O., SeyedAlinaghi, S., Karimi, A., MohsseniPour, M., Barzegary, A., Vahedi, F., Pashaei, Z., Mirzapour, P., Fakhfouri, A., Zargari, G., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00539-1 · Cited by 120 · cited 2×
“These public health efforts not only slowed down SARS‐CoV‐2 transmission but also caused a decrease of mortality rate.(1,12) In the present study, the main hypothesis along with two minor ones was discussed against the similar available studies.”
BackgroundResultSelf-citationHigher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
Hasanoğlu, İ., Korukluoğlu, G., Asiltürk, D., Coşgun, Y., Kalem, A. K., Altaş, A. B., Kayaaslan, B., Eser, F., Kuzucu, E. A., & Güner, R. (2020) · Infection · doi:10.1007/s15010-020-01548-8 · Cited by 111 · cited 3×
“The study performed by Hasanoglu et al.,59 is an example of this controversy.”
Kwon, J., Kim, J. Y., Kim, M., Park, S. Y., Kim, B.-N., Bae, S., Cha, H. H., Jung, J., Kim, M., Lee, M. J., et al. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1110 · Cited by 110 · cited 3×
“**** – ** 6 Kwon et al.(43) *** ** *** 8 Le Borgne et al.”
BackgroundValidation of mDurance, A Wearable Surface Electromyography System for Muscle Activity Assessment
Molina‐Molina, A., Ruiz‐Malagón, E. J., Carrillo‐Pérez, F., Roche-Seruendo, L. E., Damas, M., Baños, O., & García‐Pinillos, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.606287 · Cited by 110 · cited 1×
“5 | Quality/risk of bias assessment We used the Newcastle–Ottawa Scale to assess the quality of the studies.(25) This scale yields a total score out of 9 to the studies based on their selection, comparability, and exposure/outcomes.”
MethodYadav, P. D., Sapkal, G. N., Ella, R., Sahay, R. R., Nyayanit, D. A., Patil, D. Y., Deshpande, G. R., Shete, A. M., Gupta, N., Mohan, V., et al. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab104 · Cited by 108
Is Higher Viral Load in SARS-CoV-2 Associated with Death?
Faíco-Filho, K. S., Passarelli, V. C., & Bellei, N. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0954 · Cited by 104
Mirzaei, A., Rezakhani Moghaddam, H., & Habibi Soola, A. (2021) · Nursing Open · doi:10.1002/nop2.896 · Cited by 93 · cited 1×
“As of September 3, 2021, there have been more than 218 million confirmed cases of COVID‐19 and 4,526,583 death have been reported around the world.(6,7) When SARS‐CoV‐2 enters lung cells, it attacks the lower respiratory tract and attaches strongly to its receptors in the lungs; namely, angiotensin‐converting enzyme r…”
BackgroundGenomic cloud computing: legal and ethical points to consider
Public Population Project in Genomics and Society (P3G) International Steering Committee, Dove, E. S., International Cancer Genome Consortium (ICGC) Ethics and Policy Committee, Joly, Y., Tassé, A.-M., & Knoppers, B. M. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.196 · Cited by 92 · cited 1×
“Delta variant: The Delta variant is more infectious and each infected person can transmit the virus to seven or more people.(17) For the clinical management of COVID‐19 disease, it is substantial to quantify the viral load of the blood.”
BackgroundKociolek, L. K., Muller, W. J., Yee, R., Bard, J. D., Brown, C. A., Revell, P. A., Wardell, H., Savage, T. J., Jung, S. A., Dominguez, S. R., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02593-20 · Cited by 92 · cited 2×
“*** – ** 5 Kociolek et al.(41) **** ** ** 8 Kriegova et al.”
Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 89
Genetic susceptibility of COVID-19: a systematic review of current evidence
SeyedAlinaghi, S., Mehrtak, M., MohsseniPour, M., Mirzapour, P., Barzegary, A., Habibi, P., Badie, B. M., Afsahi, A. M., Karimi, A., Heydari, M., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00516-8 · Cited by 87 · cited 1×
“1–3 The World Health Organization (WHO) declared this disease as a “public health emergency of international concern” on January 30, 2020.(4,5) As of September 3, 2021, there have been more than 218 million confirmed cases of COVID‐19 and 4,526,583 death have been reported around the world.”
BackgroundSelf-citationCOVID ‐19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction
Cho, R., To, Z. W. H., Yeung, Z. W. C., Tso, E. Y. K., Fung, K. S. C., Chau, S. K., Leung, E. Y. L., Hui, T. S. C., Tsang, S., Kung, K. N., et al. (2020) · The Laryngoscope · doi:10.1002/lary.29056 · Cited by 84 · cited 3×
“*** ** ** 7 Cho et al.(31) ** – ** 4 Chua et al.”
Trunfio, M., Venuti, F., Alladio, F., Longo, B. M., Burdino, E., Cerutti, F., Ghisetti, V., Bertucci, R., Picco, C., Bonora, S., et al. (2021) · Viruses · doi:10.3390/v13020281 · Cited by 83 · cited 2×
“*** ** ** 7 Trunfio et al.(54) *** ** *** 8 Tsukagoshi et al.”
A systematic review of ECG findings in patients with COVID-19
Mehraeen, E., SeyedAlinaghi, S., Nowroozi, A. A., Dadras, O., Alilou, S., Shobeiri, P., Behnezhad, F., & Karimi, A. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.11.007 · Cited by 76 · cited 1×
“1–3 The World Health Organization (WHO) declared this disease as a “public health emergency of international concern” on January 30, 2020.(4,5) As of September 3, 2021, there have been more than 218 million confirmed cases of COVID‐19 and 4,526,583 death have been reported around the world.”
BackgroundSelf-citationYağcı, A., Sarınoğlu, R. C., Bilgin, H., Yanılmaz, Ö., Sayın, E., Deniz, G., Güncü, M. M., Doyuk, Z., Can, B., Kuzan, B. N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1449 · Cited by 71 · cited 2×
“*** – ** 5 Karahasan Yagci et al.(38) *** ** *** 8 Kawasuji et al.”
COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study
Abdulrahman, A., Mallah, S. I., & AlQahtani, M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06376-1 · Cited by 69 · cited 1×
“The lower the Ct values than a patient's sample, the higher the viral load.(20) The relationship between the viral load and severity of disease in 2 of 25 | DADRAS ET AL.”
BackgroundRelationships between Viral Load and the Clinical Course of COVID-19
Tsukagoshi, H., 篠田, 大., Saito, M., Okayama, K., Sada, M., Kimura, H., & Saruki, N. (2021) · Viruses · doi:10.3390/v13020304 · Cited by 64
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
SeyedAlinaghi, S., Abbasian, L., Solduzian, M., Yazdi, N. A., Jafari, F., Adibimehr, A., Farahani, A., Khaneshan, A. S., Alavijeh, P. E., Jahani, Z., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00513-x · Cited by 63 · cited 2×
“Eventually, the virus causes acute respiratory distress syndrome that may lead to death.(12) SARS‐CoV‐2 belongs to the Nidovirales order, Coronaviridae family, Coronavirinae subfamily, it is an enveloped virus with a positive‐sense, single‐stranded RNA genome of approximately 30 kb.”
BackgroundResultSelf-citationde la Calle, C., Lalueza, A., Mancheño‐Losa, M., de la Calle, G. M., Lora‐Tamayo, J., Arrieta, E., García‐Reyne, A., Losada, I., de Miguel, B., Díaz‐Simón, R., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04150-w · Cited by 57 · cited 3×
“Using this technique, we can gain an indirect viral load value (Ct) easily and immediately after diagnosis.(33) The main hypothesis could be explained by the association between viral load and inflammatory factors that are also clearly connected with the disease severity.”
MethodNasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
Shlomai, A., Ben‐Zvi, H., Bendersky, A. G., Shafran, N., Goldberg, E., & Sklan, E. H. (2020) · Critical Care · doi:10.1186/s13054-020-03244-3 · Cited by 47 · cited 3×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Distribution of Transmission Potential During Nonsevere COVID-19 Illness
Shrestha, N. K. M., Canosa, F. M., Nowacki, A. S., Procop, G. W., Vogel, S. A., Fraser, T. G., ERZURUM, S. C., Terpeluk, P., & Gordon, S. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa886 · Cited by 46 · cited 2×
“** – ** 4 Shrestha et al.(49) ** ** ** 6 Singanayagam et al.”
Borgne, P. L., Solis, M., Séverac, F., Merdji, H., Ruch, Y., Alamé, K., Bayle, É., Hansmann, Y., Bilbault, P., Fafi‐Kremer, S., et al. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14217 · Cited by 43 · cited 3×
“*** ** *** 8 Le Borgne et al.(44) **** ** ** 8 Piubelli et al.”
Chen, L., Wang, G., Long, X., Hou, H., Wei, J., Cao, Y., Tan, J., Liu, W., Huang, L., Meng, F., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.10.007 · Cited by 42
High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease
Soria, M. E., Cortón, M., Martínez‐González, B., Lobo-Vega, R., Vázquez-Sirvent, L., López‐Rodríguez, R., Almoguera, B., Mahíllo, I., Mínguez, P., Herrero, A., et al. (2021) · Access Microbiology · doi:10.1099/acmi.0.000259 · Cited by 42 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Aoki, K., Nagasawa, T., Ishii, Y., Yagi, S., Okuma, S., Kashiwagi, K., Maeda, T., Miyazaki, T., Yoshizawa, S., & Tateda, K. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.11.021 · Cited by 40 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
MethodSarkar, K., Sarkar, B., & Sinha, R. (2020) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_593_20 · Cited by 37 · cited 3×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
InfluentialSARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients
Buetti, N., Wicky, P.-H., Hingrat, Q. L., Ruckly, S., Mazzuchelli, T., Loiodice, A., Trimboli, P., Ogna, V. F., de Montmollin, É., Bernasconi, E., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03323-5 · Cited by 30 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Correlation Analysis between the Viral Load and the Progression of COVID-19
Chen, W., Xiao, Q., Fang, Z., Lv, X., Yao, M., & Deng, M. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/9926249 · Cited by 28 · cited 1×
“A Chinese study working on the association of viral load with the development of COVID‐19 found that patients with more viral load had fewer lymphocytes but more neutrophils.(23) In another study that examined the relationship between viral load and disease severity with COVID‐19 clinical results, viral load in severe…”
BackgroundRauch, J. N., Valois, E., Ponce-Rojas, J. C., Aralis, Z., Lach, R. S., Zappa, F., Audouard, M., Solley, S. C., Vaidya, C., Costello, M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37129 · Cited by 24 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Berastegui‐Cabrera, J., Salto‐Alejandre, S., Valerio, M., Pérez‐Palacios, P., Revillas, F. A. D. L., Abelenda-Alonso, G., Oteo, J. A., Carretero-Ledesma, M., Muñóz, P., Pascual, Á., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.11.024 · Cited by 24 · cited 2×
“*** – ** 5 Berastegui‐Cabrera et al.(28) **** ** * 7 Buetti et al.”
Is there a correlation between viral load and olfactory & taste dysfunction in COVID-19 patients?
Jain, A., Pandey, A. K., Kaur, J., Kumar, L., Singh, M., Das, S. R., & Purohit, S. (2021) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2021.102911 · Cited by 23 · cited 2×
“*** – ** 5 Jain et al.(36) **** ** ** 8 Kam et al.”
Chua, G. T., Wong, J. S. C., To, K. K., Lam, I. C. S., Yau, Y. S., Chan, W. H., Ho, P. K., Duque, J. S. R., Yip, C. C., Ng, A. C., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1878937 · Cited by 22 · cited 2×
“** – ** 4 Chua et al.(32) ** – *** 5 de la Calle et al.”
Kim, C., Kim, W., Jeon, J. H., Seok, H., Kim, S. B., Choi, H. K., Yoon, Y. K., Song, J. Y., Park, D. W., Sohn, J. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250358 · Cited by 21 · cited 2×
“** – ** 4 Kim et al.(40) *** – ** 5 Kociolek et al.”
Piubelli, C., Deiana, M., Pomari, E., Silva, R., Bisoffi, Z., Formenti, F., Perandin, F., Gobbi, F. G., & Buonfrate, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.10.006 · Cited by 20 · cited 2×
“TABLE 2 Quality assessment for the included studies using the Newcastle–Ottawa ScaleThe first author (reference) Selection (out of 4) Comparability (out of 2) Exposure/ outcome (out of 3) Total score (out of 9) Aoki et al.26 *** – ** 5 Aydin et al.27 *** – ** 5 Berastegui‐Cabrera et al.28 **** ** * 7 Buetti et al.29 *…”
Aydın, Ş., Benk, I. G., & Geçkil, A. A. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114198 · Cited by 17 · cited 3×
“*** – ** 5 Aydin et al.(27) *** – ** 5 Berastegui‐Cabrera et al.”
Metadata
- Authors
- Dadras, O., Afsahi, A. M., Pashaei, Z., Mojdeganlou, H., Karimi, A., Habibi, P., Barzegary, A., Fakhfouri, A., Mirzapour, P., Janfaza, N., Dehghani, S., Afroughi, F., Dashti, M., Khodaei, S., Mehraeen, E., Voltarelli, F., Sabatier, J., & SeyedAlinaghi, S.
- Venue
- Immunity, Inflammation and Disease
- Publisher
- Wiley
- Published
- 2021-12-13
- Volume
- 10
- Issue
- 3
- Pages
- e580-e580
- ISSN
- 2050-4527 (ISSN-L)
- OpenAlex
- W4200294380
- Cited by
- 165
- References
- 51
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.